Hengrui Pharma Reports Steady Growth in First Nine Months of 2026
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
HGTECH Says Third-Quarter Revenue Rose 41.8% Year Over Year
HGTECH said third-quarter revenue increased 41.8% from a year earlier.
M impact | EARNINGS | Oct 29, 2026, 11:27 AM UTC
Ligand Expects 2026 Adjusted EPS of $9.50-$9.75
Ligand Pharmaceuticals expects 2026 adjusted EPS of $9.50-$9.75, versus a FactSet estimate of $9.35.
M impact | EARNINGS | Oct 29, 2026, 11:27 AM UTC
Indian Energy Exchange Reports September-Quarter Revenue of 1.67 Billion Rupees
Indian Energy Exchange reported consolidated revenue from operations of 1.67 billion rupees for the September quarter.
M impact | EARNINGS | Oct 29, 2026, 11:27 AM UTC
Sirius XM Reports Q3 EPS of $0.78
M impact | EARNINGS | Oct 29, 2026, 11:26 AM UTC
Altisource Portfolio Solutions Reports Q3 Adjusted Net Income of $1.52 Million
M impact | EARNINGS | Oct 29, 2026, 11:26 AM UTC
Indian Energy Exchange Reports Sept-Quarter Net Profit of 1.39 Billion Rupees
M impact | EARNINGS | Oct 29, 2026, 11:26 AM UTC